Comparing Revenue Performance: Walgreens Boots Alliance, Inc. or Pharming Group N.V.?

Walgreens vs. Pharming: A Decade of Revenue Growth

__timestampPharming Group N.V.Walgreens Boots Alliance, Inc.
Wednesday, January 1, 20142576243976392000000
Thursday, January 1, 201511838278103444000000
Friday, January 1, 201616693660117351000000
Sunday, January 1, 2017107517335118214000000
Monday, January 1, 2018154575611131537000000
Tuesday, January 1, 2019189333721120074000000
Wednesday, January 1, 2020228394666121982000000
Friday, January 1, 2021189853037132509000000
Saturday, January 1, 2022205622000132703000000
Sunday, January 1, 2023245316000139081000000
Monday, January 1, 2024147658000000
Loading chart...

Data in motion

A Tale of Two Companies: Walgreens Boots Alliance vs. Pharming Group

In the ever-evolving landscape of the pharmaceutical and retail sectors, Walgreens Boots Alliance, Inc. and Pharming Group N.V. present a fascinating study in contrasts. Over the past decade, Walgreens Boots Alliance has consistently demonstrated robust revenue growth, with a staggering 82% increase from 2014 to 2023. In 2023 alone, their revenue reached approximately $139 billion, showcasing their dominance in the industry.

On the other hand, Pharming Group N.V., a smaller player, has shown impressive growth relative to its size. From 2014 to 2023, Pharming's revenue surged by over 850%, reflecting their strategic advancements and market penetration. Despite this growth, their revenue remains a fraction of Walgreens', highlighting the scale difference between the two companies.

This comparison underscores the diverse strategies and market positions within the pharmaceutical and retail sectors, offering valuable insights for investors and industry enthusiasts alike.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025